Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

Marlon Perera; Nathan Papa; Matthew Roberts; Michael Williams; Cristian Udovicich; Ian Vela; Daniel Christidis; Damien Bolton; Michael S. Hofman; Nathan Lawrentschuk; Declan G. Murphy

doi:10.1016/j.eururo.2019.01.049

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

Marlon Perera, Nathan Papa, Matthew Roberts, Michael Williams, Cristian Udovicich, Ian Vela, Daniel Christidis, Damien Bolton, Michael S. Hofman, Nathan Lawrentschuk, Declan G. Murphy

Research output: Contribution to journal › Review Article › Research › peer-review

708 Citations (Scopus)

Abstract

Gallium-68 prostate-specific membrane antigen positron emission tomography is now an established imaging technique that has been developed in response to inadequacies in standard-of-care imaging modalities to improve the detection of metastatic disease in prostate cancer. In light of the growing body of evidence, we summarised the data to date to provide clinicians with an overview of this imaging modality.

Original language	English
Pages (from-to)	403-417
Number of pages	15
Journal	European Urology
Volume	77
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2019.01.049
Publication status	Published - Apr 2020
Externally published	Yes

Keywords

Biochemical recurrence
Imaging
Metastases
Positron emission tomography
Prostate cancer
Prostate-specific antigen
Prostate-specific membrane antigen
Sensitivity

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2019.01.049

Cite this

Perera, M., Papa, N., Roberts, M., Williams, M., Udovicich, C., Vela, I., Christidis, D., Bolton, D., Hofman, M. S., Lawrentschuk, N., & Murphy, D. G. (2020). Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. European Urology, 77(4), 403-417. https://doi.org/10.1016/j.eururo.2019.01.049

Perera, Marlon ; Papa, Nathan ; Roberts, Matthew et al. / Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions : A Systematic Review and Meta-analysis. In: European Urology. 2020 ; Vol. 77, No. 4. pp. 403-417.

@article{337f611ff53844029233884e8359d633,

title = "Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis",

abstract = "Gallium-68 prostate-specific membrane antigen positron emission tomography is now an established imaging technique that has been developed in response to inadequacies in standard-of-care imaging modalities to improve the detection of metastatic disease in prostate cancer. In light of the growing body of evidence, we summarised the data to date to provide clinicians with an overview of this imaging modality.",

keywords = "Biochemical recurrence, Imaging, Metastases, Positron emission tomography, Prostate cancer, Prostate-specific antigen, Prostate-specific membrane antigen, Sensitivity",

author = "Marlon Perera and Nathan Papa and Matthew Roberts and Michael Williams and Cristian Udovicich and Ian Vela and Daniel Christidis and Damien Bolton and Hofman, {Michael S.} and Nathan Lawrentschuk and Murphy, {Declan G.}",

year = "2020",

month = apr,

doi = "10.1016/j.eururo.2019.01.049",

language = "English",

volume = "77",

pages = "403--417",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier BV",

number = "4",

}

Perera, M, Papa, N, Roberts, M, Williams, M, Udovicich, C, Vela, I, Christidis, D, Bolton, D, Hofman, MS, Lawrentschuk, N & Murphy, DG 2020, 'Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis', European Urology, vol. 77, no. 4, pp. 403-417. https://doi.org/10.1016/j.eururo.2019.01.049

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. / Perera, Marlon; Papa, Nathan; Roberts, Matthew et al.
In: European Urology, Vol. 77, No. 4, 04.2020, p. 403-417.

Research output: Contribution to journal › Review Article › Research › peer-review

TY - JOUR

T1 - Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions

T2 - A Systematic Review and Meta-analysis

AU - Perera, Marlon

AU - Papa, Nathan

AU - Roberts, Matthew

AU - Williams, Michael

AU - Udovicich, Cristian

AU - Vela, Ian

AU - Christidis, Daniel

AU - Bolton, Damien

AU - Hofman, Michael S.

AU - Lawrentschuk, Nathan

AU - Murphy, Declan G.

PY - 2020/4

Y1 - 2020/4

N2 - Gallium-68 prostate-specific membrane antigen positron emission tomography is now an established imaging technique that has been developed in response to inadequacies in standard-of-care imaging modalities to improve the detection of metastatic disease in prostate cancer. In light of the growing body of evidence, we summarised the data to date to provide clinicians with an overview of this imaging modality.

AB - Gallium-68 prostate-specific membrane antigen positron emission tomography is now an established imaging technique that has been developed in response to inadequacies in standard-of-care imaging modalities to improve the detection of metastatic disease in prostate cancer. In light of the growing body of evidence, we summarised the data to date to provide clinicians with an overview of this imaging modality.

KW - Biochemical recurrence

KW - Imaging

KW - Metastases

KW - Positron emission tomography

KW - Prostate cancer

KW - Prostate-specific antigen

KW - Prostate-specific membrane antigen

KW - Sensitivity

UR - http://www.scopus.com/inward/record.url?scp=85061425439&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2019.01.049

DO - 10.1016/j.eururo.2019.01.049

M3 - Review Article

C2 - 30773328

AN - SCOPUS:85061425439

SN - 0302-2838

VL - 77

SP - 403

EP - 417

JO - European Urology

JF - European Urology

IS - 4

ER -

Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I et al. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. European Urology. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Cite this